Drug Type Small molecule drug |
Synonyms CU-01, CU01-1001 |
Target |
Mechanism Nrf2 stimulants(Nuclear factor erythroid 2-related factor 2 stimulants), TGF-β inhibitors(Transforming growth factor beta inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Albuminuria | Phase 2 | KR | 25 Jan 2023 | |
Diabetes Mellitus, Noninsulin-Dependent, 2 | Phase 2 | KR | 25 Jan 2023 | |
Type 2 diabetes mellitus with established diabetic nephropathy | Phase 2 | KR | 25 Jan 2023 |